AML

You have access
The CGRP Receptor Antagonist MK0974 Induces EVI1^high AML Cell Apoptosis by Disrupting ERK Signaling
AKIRA SUEKANE, TOMONAGA ICHIKAWA, YUSUKE SAITO, SHINGO NAKAHATA and KAZUHIRO MORISHITA

Anticancer Research October 2022, 42 (10) 4743-4752; DOI: https://doi.org/10.21873/anticanres.15979
You have access
Anti-leukemic Activity of AIU2008 in FLT3-ITD-positive Acute Myeloid Leukemia
HYO JEONG KIM, HWANI RYU, HYUN-KYUNG CHOI, JIE-YOUNG SONG, SANG-GU HWANG and JIYEON AHN

Anticancer Research February 2021, 41 (2) 731-737; DOI: https://doi.org/10.21873/anticanres.14824
You have access
Unusual Karyotype in Acute Myelomonocitic Leukemia: A Case Report
MARIA LETIZIA CONSOLI, ALESSANDRA ROMANO, NUNZIATINA LAURA PARRINELLO, LOREDANA TAMBÈ, MARIA ANNA ROMEO, DOMENICO SALEMI, ALESSANDRA SANTORO and FRANCESCO DI RAIMONDO

Anticancer Research August 2019, 39 (8) 4329-4332; DOI: https://doi.org/10.21873/anticanres.13599
You have access
TAK-733, a Selective MEK Inhibitor, Enhances Voreloxin-induced Apoptosis in Myeloid Leukemia Cells
EWA JASEK-GAJDA, MARIUSZ GAJDA, MAŁGORZATA JASIŃSKA, JAN A. LITWIN and GRZEGORZ J. LIS

Anticancer Research November 2018, 38 (11) 6147-6156; DOI: https://doi.org/10.21873/anticanres.12967
You have access
Efficacy and Toxicity of Induction Therapy with Cladribine, Idarubicin, and Cytarabine (IAC) for Acute Myeloid Leukemia
SUSAN K. WOELICH, JAMES T. BRAUN, MARTIN W. SCHOEN, RESHMA RAMLAL, CARL E. FRETER, PAUL J. PETRUSKA and JACK M. LIONBERGER

Anticancer Research February 2017, 37 (2) 713-717;
You have access
Kinomics Screening Identifies Aberrant Phosphorylation of CDC25C in FLT3-ITD-positive AML
FLORIAN PERNER, TINA M. SCHNÖDER, THOMAS FISCHER and FLORIAN H. HEIDEL

Anticancer Research December 2016, 36 (12) 6249-6258;
You have access
Insurance Status and Other Non-biological Factors Predict Outcomes in Acute Myelogenous Leukemia: Analysis of Data from the National Cancer Database
SAMIP MASTER, REINHOLD MUNKER, ZHENZHEN SHI, GLENN MILLS and RUNHUA SHI

Anticancer Research September 2016, 36 (9) 4915-4921;
You have access
Predictors of Survival in Acute Myeloid Leukemia by Treatment Modality
SAMIP MASTER, RICHARD MANSOUR, SRINIVAS S. DEVARAKONDA, ZHENZHEN SHI, GLENN MILLS and RUNHUA SHI

Anticancer Research April 2016, 36 (4) 1719-1727;
You have access
The Response to Induction Therapy Is Crucial for the Treatment Outcomes of Elderly Patients with Acute Myeloid Leukemia: Single-institution Experience
TOSHIKI TASAKI, TAKAHIRO YAMAUCHI, YASUFUMI MATSUDA, MIHOKO TAKAI, MIYUKI OOKURA, SHIN LEE, KATSUNORI TAI, SATOSHI IKEGAYA, SHINJI KISHI, AKIRA YOSHIDA, YOSHIMASA URASAKI, HIROMICHI IWASAKI and TAKANORI UEDA

Anticancer Research October 2014, 34 (10) 5631-5636;
You have access
Second Primary Malignancies in Adult Acute Myeloid Leukemia - A US Population-based Study
KRISHNA BILAS GHIMIRE and BINAY KUMAR SHAH

Anticancer Research July 2014, 34 (7) 3855-3859;

Main menu

User menu

Search

AML

Pages